JNK is associated with Bcl-2 and PP1 in mitochondria: paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2

Autor: Annie Valette, Gabrielle Cazettes, Laetitia Brichese
Přispěvatelé: Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération (LBCMCP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre de Biologie Intégrative (CBI), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2004
Předmět:
Cell cycle checkpoint
Time Factors
Mitochondrion
0302 clinical medicine
Cytosol
MESH: Cytosol
Phosphoprotein Phosphatases
Phosphorylation
0303 health sciences
Kinase
Cell biology
Mitochondria
Protein Transport
Proto-Oncogene Proteins c-bcl-2
030220 oncology & carcinogenesis
Cell fractionation
MESH: Protein Transport
MESH: Enzyme Activation
MESH: Cell Line
Tumor

Paclitaxel
MESH: Mitochondria
Immunocytochemistry
Phosphatase
Mitosis
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Biology
Cyclin B
Models
Biological

03 medical and health sciences
Cell Line
Tumor

MESH: Phosphoprotein Phosphatases
Mitotic Index
Humans
MESH: Paclitaxel
Molecular Biology
030304 developmental biology
MESH: Mitotic Index
MESH: Humans
MESH: Phosphorylation
MESH: Time Factors
JNK Mitogen-Activated Protein Kinases
MESH: Models
Biological

Cell Biology
MESH: Cyclin B
MESH: JNK Mitogen-Activated Protein Kinases
MESH: Mitosis
Enzyme Activation
MESH: Hela Cells
MESH: Proto-Oncogene Proteins c-bcl-2
Developmental Biology
HeLa Cells
Zdroj: Cell Cycle
Cell Cycle, Taylor & Francis, 2004, 3 (10), pp.1312-9
ISSN: 1538-4101
1551-4005
Popis: It has been shown that the activation of JNK after paclitaxel-induced microtubule damage is parallel to Bcl-2 phosphorylation, cell cycle arrest in mitosis and apoptosis. Using subcellular fractionation and immunocytochemistry, we found here that a pool of activated JNK is located in mitochondria of HeLa cells treated with paclitaxel. Furthermore, whereas the JNK protein is present in a tripartite complex with the anti-apoptotic Bcl-2 protein and the PP1 phosphatase in mitochondria isolated from control cells, the activated form of JNK was associated with the phosphorylated form of Bcl-2, but devoid of PP1, in mitochondria isolated from paclitaxel-treated cells. Moreover, using an original cell-free system, we evidenced a direct involvement of JNK as the kinase responsible for the phosphorylation of mitochondrial Bcl-2 in mitotic arrested cells. Indeed, cytosols prepared from mitotic arrested cells led to a dose-dependent phosphorylation of mitochondrial Bcl-2. Bcl-2 phosphorylation was inhibited by CEP 11004, a JNK pathway inhibitor and by immunodepletion of JNK. Taken together, these data show that JNK activation provides a molecular linkage from microtubule damages to the mitochondrial apoptotic machinery and also point to a pivotal role for the JNK/Bcl-2/PP1 complex in the control of apoptosis following paclitaxel treatment.
Databáze: OpenAIRE